Skip to main content
Click Here For COVID-19 Studies
Home
Clinical Trials Office Register as a Researcher Log In
229 Studies Now Enrolling
 Menu
Home How It Works Resources Join RecruitMe

Search

Reset

Status

  • Currently Recruiting (2)
  • Closed (1)

Medical Condition

  • Show all (171)
  • Blood Disorders (1)
  • Cancer (100)
  • COVID-19 (Coronavirus) (1)
  • Diabetes (2)
  • (-) Ear, Nose and Throat (1)
    • Hearing Loss (1)
  • Endocrine & Metabolic Disease (2)
  • Gastrointestinal and Digestive Diseases (2)
  • Healthy Volunteers (7)
  • Heart Disease (2)
  • Liver Disease (1)
  • Neurological Disorders (3)
  • (-) Obesity (2)
  • Obstetrics & Gynecology (6)
  • Pediatrics (37)
  • Psychiatric Disorders (1)
  • Surgery (1)
  • Transplant (2)
Displaying 1 - 3 of 3

Alpelisib Challenge Test (ACT)

Condition: Obesity
Investigator: Joshua Cook, MD, PhD
Status: Currently Recruiting
We are recruiting volunteers, aged 18-70 without diabetes, for a research study on determining how much of the blood sugar- lowering hormone insulin the body can produce in order to better identify people at risk for diabetes in the future. To do this, we will have approximately 15 participants stay for approximately 30 hours (including overnight) in the…
Read More

Temporary Insulin Resistance

Condition: Obesity
Investigator: Joshua Cook, MD, PhD
Status: Currently Recruiting
We are recruiting volunteers, aged 18-70, for a research study on the buildup of excessive liver fat ("fatty liver disease") in people with or at risk for type 2 diabetes because their bodies are resistant to the actions of the blood sugar-lowering hormone, insulin. To do this, we seek to temporarily induce or accentuate insulin resistance in 14 volunteers…
Read More

A study to Assess Safety and Effectiveness of Study Drug OTO-104 in Patients at Risk of Hearing Loss From Cisplatin Chemotherapy

Condition: Ear, Nose and Throat / Hearing Loss
Investigator: Alice Lee, MD
Status: Closed
Cisplatin is a chemotherapy medicine that is used to treat a variety of cancers. At high total (cumulative) doses it can be associated with progressive and irreversible hearing loss. The purpose of this study is see if injections of OTO-104 can protect against hearing loss associated with cisplatin therapy in the treatment of…
Read More
COMPLIANCE
Compliance Hotline Compliance Program
RESOURCES
Terms of Use Privacy Policy ©2026 Columbia University
SCHOOLS
Vagelos College of Physicians and Surgeons Mailman School of Public Health School of Nursing College of Dental Medicine Graduate School of Arts and Science